
CAS 1620758-32-8
:Empagliflozin Impurity 50 (Mixture of Diastereomers)
CAS:Formula:C23H27ClO7Color and Shape:White To Off-White SolidMolecular weight:450.91Empagliflozin Impurity 54
CAS:Formula:C23H27ClO7Color and Shape:White To Off-White SolidMolecular weight:450.91Empagliflozin R/S-Furanose
CAS:Applications Empagliflozin R/S-Furanose is a mixture of R and S isomers of Empagliflozin Furanose. Both are byproducts in the synthesis of Empagliflozin drug (E521510), which is potent and selective inhibitor of sodium glucose co-transporter-2 (SGLT-2).
References Thomas, L., et al.: Diabetes. Obesity. Metabol. 14, 94 (2012); Grempler, R., et al.: Diabetes. Obesity. Metabol., 14, 83 (2012); Wang, X., et al.: Org. Lett., 16, 4090 (2014);Formula:C23H27ClO7Color and Shape:White To Off-WhiteMolecular weight:450.9091,4-Anhydro-1,5-dihydroxy-empagliflozin-d4
CAS:Controlled ProductFormula:C23H23D4ClO7Color and Shape:NeatMolecular weight:454.93Empagliflozin S-furanose
CAS:Empagliflozin S-furanose is a Custom synthesis drug product. It is an analytical standard with CAS No. 1620758-32-8, and it is used in research and development of new drugs. Empagliflozin S-furanose has been found to be a metabolite of empagliflozin, a drug that is used to treat type 2 diabetes mellitus. It is also used as an impurity standard for HPLC analysis of empagliflozin because it does not have any biological activity.
Formula:C23H27ClO7Purity:Min. 95%Color and Shape:PowderMolecular weight:450.91 g/mol



